Zhibao Technology Inc. announced the launch of ten new artificial‑intelligence agents that will be embedded across product management, application development, and underwriting functions of its digital insurance platform. The agents are designed to generate more than half of the code written each day and to auto‑create product ranking documentation, thereby shortening the development cycle and reducing manual effort.
The new agents extend the company’s Platform as a Service (PaaS) ecosystem, which already supports more than 40 digital insurance products for B‑channel partners such as e‑commerce and logistics firms. By automating core workflow steps, Zhibao expects to cut time‑to‑market for new insurance offerings and improve conversion rates for its 2B2C model, where the platform serves both business customers and their end users.
The announcement follows the 2025 launch of the ZBOT AI agent and signals a continued investment in automation and scalability. Management said the new agents are a tangible execution of the company’s strategy to become an “intelligence‑driven technology enterprise” and that they will enable the firm to provide even more efficient services to its B‑channel partners and end customers.
In the fourth quarter of 2025, Zhibao reported revenue of $9.3 million, up 39.1 % from the prior year, and a gross profit of $5.0 million, a 65.9 % increase. The company posted an operating loss of $4.0 million and a net loss of $4.2 million, with diluted earnings per share of –$0.09. For the full year ended June 30 2025, revenue rose 51 % to RMB 276.9 million (US$38.7 million), gross margin was 41 %, and the company recorded a net loss of RMB 62.0 million (US$8.7 million).
The new AI agents are expected to lower operating costs by reducing the manual coding workload and speeding up product development, which could accelerate revenue growth from brokerage and managing general agent (MGU) services. The company’s recent regain of Nasdaq listing compliance in January and the launch of a joint venture focused on medical insurance products in December 2025 further support its expansion strategy.
Investors view the AI launch as a catalyst for a positive market reaction, reflecting confidence in Zhibao’s ability to leverage technology to differentiate itself from traditional insurers and other InsurTech competitors in China’s emerging embedded‑insurance market.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.